Chromosome 20p Deletion: Clinical Management
Patients with chromosome 20p deletion require immediate referral to a multidisciplinary team including an epileptologist, genetic counselor, and allied health specialists, with families counseled that epilepsy—when present—will likely be drug-resistant and lifelong.
Clinical Presentation
Ring Chromosome 20 (Most Common 20p Abnormality)
Ring chromosome 20 presents as a developmental and epileptic encephalopathy with characteristic features 1:
- Initial development typically normal (~85% have normal early milestones)
- Developmental plateau or regression occurs with seizure onset
- Drug-resistant focal seizures are the hallmark
- Non-convulsive status epilepticus (NCSE) occurs frequently and is a critical diagnostic consideration
- Intellectual disability affects the majority, though severity varies with degree of cellular mosaicism
- Behavioral manifestations: attention deficit, impulsivity, aggression, executive dysfunction, obsessive-compulsive traits, autism spectrum features 1
- Subtle dysmorphic features (when present): microcephaly, dental malocclusions, cauliflower-shaped ears 1
Critical pitfall: The degree of cellular mosaicism correlates significantly with age at seizure onset and cognitive impairment severity 1.
Terminal 20p13 Deletions
These present with a more recognizable phenotype 2, 3, 4:
- Mental retardation and epilepsy (major diagnostic criteria)
- Dysmorphic features: low-set ears with overfolded helices, prominent ear lobes, prominent nasal root/ridge, thin upper lip
- Short stature (present in 50% of reported cases—this is a key feature) 4
- Delayed fontanelle closure and permanent teeth eruption
- Brachydactyly and hypoplastic fingernails 3
- Visual disturbances
Interstitial 20p11-p12 Deletions
- Panhypopituitarism with hypoplastic/ectopic pituitary gland
- Cleft lip and palate
- Seizure disorder
- Metabolic disturbances (hypoglycemia with high anion gap metabolic acidosis)
- Growth hormone resistance (low IGF-1 despite treatment)
- Midline brain structure abnormalities
Diagnostic Evaluation
Genetic Testing Strategy
Critical diagnostic consideration: Ring chromosome 20 is likely underdiagnosed because standard next-generation sequencing may miss it 1:
- Conventional karyotype is essential for detecting ring chromosomes, especially complete rings without genetic material loss
- Chromosomal microarray, gene panels, and whole exome/genome sequencing may all be normal in complete ring chromosomes
- Array CGH delineates deletion boundaries in terminal/interstitial deletions 3, 7
- MLPA can identify subtelomeric deletions 3
Neurological Workup
- Video-EEG monitoring should have a low threshold for any behavioral change or altered consciousness given high NCSE risk 1
- Brain MRI to evaluate for structural abnormalities (particularly pituitary/midline structures in 20p11 deletions) 5
- Neuropsychological evaluation for school-age children to optimize educational planning 1
Additional Evaluations
- Cardiac evaluation (ventricular septal defects, pulmonary hypertension reported) 8
- Endocrine assessment if growth failure or pituitary dysfunction suspected 5, 6
- Ophthalmologic examination 2
Management Recommendations
Multidisciplinary Care Team (Moderate Quality Evidence)
Essential team members 1:
- Epileptologist (early referral to tertiary/quaternary epilepsy center for drug-resistant epilepsy)
- Genetic counselor (discuss mosaicism, prognosis, inheritance risk)
- Speech-language pathologist
- Occupational therapist
- Physiotherapist
- Psychologist/psychiatrist (for behavioral issues, ideally with neurodevelopmental expertise)
Epilepsy Management
Counseling priorities (High Quality Evidence) 1:
- Seizures will likely be drug-resistant and lifelong
- NCSE risk is substantial—educate caregivers on warning signs
- Developmental plateau/regression may occur with seizure onset
Treatment algorithm 1:
- Initial treatment: Oral anti-seizure medication
- Home rescue medication: Consider given prolonged seizure/NCSE risk
- For drug-resistant epilepsy, consider:
- Ketogenic diet
- Vagus nerve stimulation
- Deep brain stimulation
Important caveat: Levetiracetam may exacerbate behavioral issues 1.
Developmental Support
- Speech, occupational, and physiotherapy evaluations for all affected children to optimize long-term developmental trajectory 1
- Appropriate educational environment based on neuropsychological testing
Transition Planning
Begin in early adolescence to prepare for adult care transition, addressing 1:
- New geographic location for care
- Potentially reduced access to allied health services
- Increased patient autonomy
Caregiver Support
Screen for and address caregiver burnout 1:
- Monitor for mood disorders and mental health issues
- Refer to psychology/psychiatry when indicated
- Offer respite care and other supports
This is critical: Caregivers report that adult neurology teams are often unfamiliar with this ultra-rare disorder, and having drug-resistant epilepsy independently increases caregiver stress and burden 1.
Prognosis Counseling
- Seizure control is typically poor despite multiple interventions
- Quality of life is significantly impacted by seizure burden
- Sudden unexpected death in epilepsy (SUDEP) risk should be discussed 1